phenylalanine and exendin (9-39)

phenylalanine has been researched along with exendin (9-39) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duffy, NA; Flatt, PR; Gault, VA; Green, BD; Irwin, N; McKillop, AM; O'Harte, FP1

Other Studies

1 other study(ies) available for phenylalanine and exendin (9-39)

ArticleYear
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
    European journal of pharmacology, 2007, Jul-30, Volume: 568, Issue:1-3

    Topics: Animals; Blood Glucose; Cell Line; Cyclohexanes; Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Mice; Mice, Obese; Nateglinide; Peptide Fragments; Phenylalanine

2007